• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Deep cervical lymphaticovenous anastomosis in Alzheimer's disease: A promising frontier or premature enthusiasm?

作者信息

Ma Ya-Nan, Wang Zijie, Tang Wei

机构信息

Department of Neurosurgery, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China.

International Health Care Center, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.

出版信息

Biosci Trends. 2025 May 9;19(2):144-149. doi: 10.5582/bst.2025.01108. Epub 2025 Apr 15.

DOI:10.5582/bst.2025.01108
PMID:40240169
Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder marked by β-amyloid accumulation, tau pathology, and impaired metabolic waste clearance. Recent evidence suggests that meningeal lymphatic vessels (MLVs) contribute significantly to the drainage of cerebrospinal and interstitial fluid. Deep cervical lymphaticovenous anastomosis (LVA), a microsurgical technique designed to enhance this drainage, has been proposed as a potential therapeutic strategy for AD. Preliminary findings from exploratory studies in China indicate possible cognitive and biomarker improvements, but current evidence is limited by small sample sizes, non-randomized designs, and methodological variability. Without standardized protocols and rigorous clinical validation, the broader applicability of LVA remains uncertain. Further investigation through multicenter, controlled trials is essential to objectively assessing its safety, efficacy, and clinical relevance in the management of AD.

摘要

相似文献

1
Deep cervical lymphaticovenous anastomosis in Alzheimer's disease: A promising frontier or premature enthusiasm?
Biosci Trends. 2025 May 9;19(2):144-149. doi: 10.5582/bst.2025.01108. Epub 2025 Apr 15.
2
A Novel Microsurgical Model of Cervical Lymph Node-to-Vein Anastomosis (LNVA) for Studying Brain Lymphatic Outflow.一种用于研究脑淋巴引流的新型颈淋巴结-静脉吻合术(LNVA)显微外科模型。
J Craniofac Surg. 2025 Sep 1;36(6):2160-2163. doi: 10.1097/SCS.0000000000011535. Epub 2025 Jun 18.
3
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
4
Galantamine for Alzheimer's disease.加兰他敏用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2002(3):CD001747. doi: 10.1002/14651858.CD001747.
5
Galantamine for Alzheimer's disease.加兰他敏用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2001(4):CD001747. doi: 10.1002/14651858.CD001747.
6
Physostigmine for Alzheimer's disease.用于治疗阿尔茨海默病的毒扁豆碱。
Cochrane Database Syst Rev. 2001;2001(2):CD001499. doi: 10.1002/14651858.CD001499.
7
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
8
WITHDRAWN: Tacrine for Alzheimer's disease.撤回:他克林用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2007 Jul 18(3):CD000202. doi: 10.1002/14651858.CD000202.
9
Galantamine for Alzheimer's disease and mild cognitive impairment.加兰他敏用于治疗阿尔茨海默病和轻度认知障碍。
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD001747. doi: 10.1002/14651858.CD001747.pub3.
10
Tacrine for Alzheimer's disease.他克林用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2000;1999(2):CD000202. doi: 10.1002/14651858.CD000202.

引用本文的文献

1
Targeting the glymphatic system: Aβ accumulation and phototherapy strategies across different stages of Alzheimer's disease.靶向类淋巴系统:阿尔茨海默病不同阶段的β淀粉样蛋白积累与光疗策略
Transl Neurodegener. 2025 Sep 24;14(1):49. doi: 10.1186/s40035-025-00510-8.